Mitigating Emergency Drug Shortages Act
Bill journey · stage 2 of 5
Under committee review
What it doesSummary introduced in senate (Oct 29, 2019)
Mitigating Emergency Drug Shortages Act
This bill requires the Food and Drug Administration (FDA) to prioritize the review of life-saving or life-sustaining drugs that are facing shortages. The bill also requires manufacturers to report certain information to the FDA when there is a permanent discontinuance or interruption in the manufacture of active pharmaceutical ingredients for such drugs.
What just happenedOct 29, 2019
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6245-6246)
Who’s behind it
- Introduced in SenateOct 29, 2019
- Oct 29, 2019IntroReferral
Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (Sponsor introductory remarks on measure: CR S6245-6246)
Health, Education, Labor, and Pensions Committee - Oct 29, 2019IntroReferral10000
Introduced in Senate